Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-23 · accession 0001209191-22-031844 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-25 | 2022-05-23 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $11.50 | -36.3K | 832.6K | -4% | -$417.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-05-23 | S | D | 11,848 | $11.50 | 798,881 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-05-23 | S | D | 21,873 | $11.50 | 810,729 | D | — | — | |
| 3 | Common | Class A Common Stock | 2022-05-23 | S | D | 2,587 | $11.50 | 832,602 | D | — | — |